| Butyrate decreases its own oxidation in colorectal cancer cells through inhibition of histone deacetylases A Han, N Bennett, B Ahmed, J Whelan, DR Donohoe Oncotarget 9 (43), 27280, 2018 | 51 | 2018 |
| Cellular Metabolism and Dose Reveal Carnitine‐Dependent and‐Independent Mechanisms of Butyrate Oxidation in Colorectal Cancer Cells A Han, N Bennett, A MacDonald, M Johnstone, J Whelan, DR Donohoe Journal of cellular physiology 231 (8), 1804-1813, 2016 | 23 | 2016 |
| Characterization of the Pro‐Inflammatory Cytokine IL‐1β on Butyrate Oxidation in Colorectal Cancer Cells M Johnstone, N Bennett, C Standifer, A Smith, A Han, A Bettaieb, ... Journal of cellular biochemistry 118 (6), 1614-1621, 2017 | 19 | 2017 |
| Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction DC Florian, NE Bennett, M Odziomek, JJ Baljon, M Wehbe, AR Merkel, ... Cancer Research Communications 3 (2), 223-234, 2023 | 1 | 2023 |
| Targeting hedgehog-driven mechanisms of drug-resistant cancers JS Miller, NE Bennett, JA Rhoades Frontiers in Molecular Biosciences 10, 2023 | 1 | 2023 |
| Bioinformatics Screen Reveals Gli-Mediated Hedgehog Signaling as an Associated Pathway to Poor Immune Infiltration of Dedifferentiated Liposarcoma EP Beadle, NE Bennett, JA Rhoades Cancers 15 (13), 3360, 2023 | | 2023 |
| EphA2 Expression in Breast Cancer Mediates Osteoclast Expansion and Promotes Osteolytic Bone Metastasis D Parker, V Ngwa, L Northcutt, N Bennett, E Beadle, J Miller, JI Chen, ... Cancer Research 83 (7_Supplement), 1324-1324, 2023 | | 2023 |
| Utilization of KRAS mutation status testing in stage IV colorectal cancer (CRC) patients in the United States: National Cancer Data Base (NCDB) analysis. A Orucevic, N Bennett, KD Gray, JL Bell, H Robert Journal of Clinical Oncology 35 (15_suppl), e15172-e15172, 2017 | | 2017 |
